The Effects of Hormonal Therapy on Quality of Life in Prostate Cancer

被引：1

作者：

Senoglu, Yusuf ^{[1
]}

Cam, Kamil ^{[2
]}

机构：

[1] Aliaga Devlet Hastanesi, Urol Klinigi, Izmir, Turkey

[2] Marmara Univ, Tip Fak, Urol Anabilim Dali, Istanbul, Turkey

来源：

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY | 2015年 / 14卷 / 04期

关键词：

Prostate cancer; quality of life; hormonal therapy;

D O I：

10.4274/uob.463

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The incidence of prostate cancer is dramatically increasing. Androgen blockade is widely utilized in the management of metastatic and locally advanced prostate cancer. Despite the benefits of this treatment, side effects and shortcoming of quality of life (QoL) constitute the major drawbacks of the hormonal treatment. The proper approach includes precautions in order to provide a lesser impairment in QoL. Therefore, physicians should consider the complications of hormonal treatment and should inform their patients. This review was prepared to point out the QoL changes regarding the hormonal treatment.

引用

页码：317 / 320

页数：4

共 43 条

[1] One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men [J].

Almeida, OP ;

Waterreus, A ;

Spry, N ;

Flicker, L ;

Martins, RN .

PSYCHONEUROENDOCRINOLOGY, 2004, 29 (08) :1071-1081

[2] EAU guidelines on prostate cancer [J].

Aus, G ;

Abbou, CC ;

Bolla, M ;

Heidenreich, A ;

Schmid, HP ;

van Poppel, H ;

Wolff, J ;

Zattoni, F .

EUROPEAN UROLOGY, 2005, 48 (04) :546-551

[3]

Beer TM, 2004, J CLIN ONCOL, V22, p419S

[4]

Bloomfield DJ, 2004, J CLIN ONCOL, V22, p418S

[5] Intermittent Androgen Deprivation for Locally Advanced and Metastatic Prostate Cancer: Results from a Randomised Phase 3 Study of the South European Uroncological Group [J].

Calais da Silva, Fernando E. C. ;

Bono, Aldo V. ;

Whelan, Peter ;

Brausi, Maurizio ;

Marques Queimadelos, Anton ;

Portillo Martin, Jose A. ;

Kirkali, Ziya ;

Calais da Silva, Fernando M. V. ;

Robertson, Chris .

EUROPEAN UROLOGY, 2009, 55 (06) :1269-1277

[6] Mortality and institutionalization following hip fracture [J].

Cree, M ;

Soskolne, CL ;

Belseck, E ;

Hornig, J ;

McElhaney, JE ;

Brant, R ;

Suarez-Almazor, M .

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2000, 48 (03) :283-288

[7] Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention [J].

Culos-Reed, S. Nicole ;

Robinson, John W. ;

Lau, Harold ;

Stephenson, Lynette ;

Keats, Melanie ;

Norris, Steve ;

Kline, Greg ;

Faris, Peter .

SUPPORTIVE CARE IN CANCER, 2010, 18 (05) :591-599

[8]

Da Silva FC, 2005, AUA ANN M, P21

[9] Locally Advanced and Metastatic Prostate Cancer Treated with Intermittent Androgen Monotherapy or Maximal Androgen Blockade: Results from a Randomised Phase 3 Study by the South European Uroncological Group [J].

da Silva, Fernando Calais ;

Calais da Silva, Fernando Manuel ;

Goncalves, Frederico ;

Santos, Americo ;

Kliment, Jan ;

Whelan, Peter ;

Oliver, Tim ;

Antoniou, Nicos ;

Pastidis, Spiro ;

Queimadelos, Anton Marques ;

Robertson, Chris .

EUROPEAN UROLOGY, 2014, 66 (02) :232-239

[10] Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study [J].

De Angelis, Roberta ;

Sant, Milena ;

Coleman, Michel P. ;

Francisci, Silvia ;

Baili, Paolo ;

Pierannunzio, Daniela ;

Trama, Annalisa ;

Visser, Otto ;

Brenner, Hermann ;

Ardanaz, Eva ;

Bielska-Lasota, Magdalena ;

Engholm, Gerda ;

Nennecke, Alice ;

Siesling, Sabine ;

Berrino, Franco ;

Capocaccia, Riccardo .

LANCET ONCOLOGY, 2014, 15 (01) :23-34

← 1 2 3 4 5 →